Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Anticancer Agents Med Chem. 2017;17(1):48–56.

Table 1.

Physicochemical characterization of rapamycin and paclitaxel/rapamycin-loaded liposomes.

Formulation Encapsulation Efficiency (%) Particle Size (nm) Polydispersity Zeta potential (mv)
DPPC:RAP (10:1) 40.74 ± 7.45 145.91 ± 1.84 0.26 ± 0.05 −14.30±1.95
DSPC:RAP (10:1) 44,23±5.98 202.65 ± 10.15 0.76 ± 0.05 −14.77 ± 1.06
DOPE:AO:RAP (10:2.5:1) 45.32 ± 3.98 167.10 ± 1.84 1.16 ± 0.01 −48.73 ± 2.14
SPC:RAP (10:1) 88.42 ± 4.92 130.15 ± 1.20 0.32 ± 0.02 −35.96 ± 2.60
SPC:Chol:RAP (10:1:1) 48.42 ± 5.67 158.60 ± 10.93 0.36 ± 0.09 −27.83 ± 1.25
SPC:Chol:RAP (10:2:1) 66.67 ± 6,76 142.15 ± 6.43 0.24 ± 0.04 −27.50 ± 0.78
SPC:Chol :RAP(10:3:1) 62.67 ± 9,34 135.25 ± 10.45 0.41 ± 0.01 −26.23 ± 0.70
SPC:Chol:DSPE-PEG2000:RAP (10:2:0.5:1) 59.58 ± 4.97 133.84 ± 8.35 0.26 ± 0.01 −3.51 ± 0.24